Microscopic colitis associated with celiac disease probably triggered by the administration of venlafaxine;Association d'une colite lymphocytaire à une maladie cœliaque probablement déclenchée par la prise de venlafaxine (Effexor®)

Revue de Medecine Interne

Volumn 30, Issue 1, 2009, Pages 74-77

  Bechade D ^a   Carmoi, T ^a   Bonnefoy, S ^a   Blondon, H ^a   Desrame J ^a   Algayres, J P ^a  

^a University of Paris Descartes   (France)

Author keywords

Celiac disease; Lymphocytic colitis; Venlafaxine

Indexed keywords

ANAFRAMIL; BUDESONIDE; CLOMIPRAMINE; COLESTYRAMINE; LOPERAMIDE 1 OXIDE; MESALAZINE; PAROXETINE; RAFTON; UNCLASSIFIED DRUG; VENLAFAXINE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CELIAC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; LABORATORY TEST; MALE; MICROSCOPIC COLITIS;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIOPSY; CELIAC DISEASE; COLITIS, MICROSCOPIC; COLON; COLONOSCOPY; CYCLOHEXANOLS; DEPRESSIVE DISORDER; HUMANS; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 57749122232     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.04.005     Document Type: Article

References (21)

1. Lazenby A.J., Yardley J.H., Giardello F.M., Jessurum J., and Bayless T.M. Lymphocytic ("microscopic") colitis: A comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 20 (1989) 18-28
2. Olensen M., Eriksson S., Bohr J., Jarnerot G., and Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Örebro, Sweden, 1993-1998. Gut 53 (2004) 346-350
3. Gillett H.R., and Freeman H.J. Prevalence of celiac disease in collagenous and lymphocytic colitis. Can J Gastroenterol 14 (2000) 919-921
4. Matteoni C.A., Goldblum J.R., Wang N., Brzezinski A., Achkar E., and Soffer E.E. Celiac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol 32 (2001) 225-227
5. Fine K.D., Do K., Schulte K., Ogunji F., Guerra R., Osowski L., et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 95 (2000) 1974-1982
6. Giardiello F.M., Lazenby A.J., Yardley J.H., Bias W.B., Johnson J., Alianiello R.G., et al. Increased HLA A1 and diminished HLA A3 in lymphocytic colitis compared to controls and patients with collagenous colitis. Dig Dis Sci 37 (1992) 496-499
7. Demarchi M., Carbonara A., Ansaldi N., Santini B., Barbera C., Borelli I., et al. HLA-DR3 and DR7 in coeliac disease: Immunogenetic and clinical aspects. Gut 24 (1983) 706-712
8. Mosnier J.F., Larvol L., Barge J., Dubois S., de la Bigne G., Henin D., et al. Lymphocytic and collagenous colitis: An immunohistochemical study. Am J Gastroenterol 91 (1996) 709-713
9. Green P.H.R. The many faces of celiac disease: Clinical presentation of celiac disease in the adult population. Gastroenterology 128 (2005) S74-S78
10. Nielsen O.H., Vainer B., and Schaffalitzky de Muckadell O.B. Microscopic colitis: a missed diagnosis?. Lancet 364 (2004) 2055-2057
11. Ventura A., Magazzu G., and Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 117 (1999) 297-303
12. Isenberg D.A. Secondary Sjögren's syndrome - The sausage factory revisited. Clin Exp Rheumatol 12 (1994) S19-S21
13. Dubois R., Lazenby A., Yardley J., Hendrix T., Bayless T., and Giardiello F. Lymphocytic enterocolitis in patients with "refractory sprue". JAMA 262 (1989) 935-937
14. Fine K.D., Lee E.L., and Meyer R. Colonic histopathology in untreated celiac sprue or refractory sprue: Is it lymphocytic colitis or colonic lymphocytosis?. Hum Pathol 29 (1998) 1433-1440
15. Bégaud B., Evreux J.C., Jouglard J., and Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 40 (1985) 111-118
16. Beaugerie L. Imputation des diarrhées et des entérocolites aux médicaments. Approche actuelle et perspectives d'amélioration. Gastroenterol Clin Biol 22 (1998) 773-777
17. Siproudhis L., Mahmoud H., Briand N., Juguet F., Bretagne J.F., Allain H., et al. Responsabilité des médicaments dans la survenue des colites aiguës. Résultats d'une étude prospective de 58 cas consécutifs. Gastroenterol Clin Biol 22 (1998) 778-784
18. Pardi D.S., Ramnath V.R., Loftus E.V., Tremaine W.J., and Sandborn W.J. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 97 (2002) 2829-2833
19. Brar P., Lee S., Lewis S., Egbuna I., Bhagat G., and Green P.H. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol 102 (2007) 2265-2269
20. Freeman H.J. Collagenous colitis as the presenting feature of biopsy-defined celiac disease. J Clin Gastroenterol 38 (2004) 664-668
21. Leffler D.A., Dennis M., Hyett B., Kelly E., Schuppan D., and Kelly C.P. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 5 (2007) 4454-4550